Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash $ 9,601,298 $ 7,150,695
Prepaid expenses and other current assets 473,834 268,677
Australia research and development incentives receivable 77,347 144,680
Total current assets 10,152,479 7,564,052
Other assets 2,800 2,800
Total assets 10,155,279 7,566,852
Current liabilities:    
Accounts payable 1,512,436 1,638,546
Accrued expenses 2,317,602 3,298,607
Total current liabilities 3,830,038 4,937,153
Long term liabilities:    
Warrant liability 2,690,605 2,152,188
Total liabilities 6,520,643 7,089,341
Commitments and contingencies (Note 7)
Stockholders' equity (deficit)    
Preferred stock, $0.0001 par value, 30,000,000 shares authorized at December 31, 2024 and December 31, 2023, 0 shares issued and outstanding
Common stock, $0.0001 par value, 70,000,000 shares authorized at December 31, 2024 and December 31, 2023, 26,157,788 and 16,986,254 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively 2,616 1,699
Additional paid-in capital 90,897,468 64,472,249
Accumulated deficit (87,234,833) (63,980,177)
Accumulated other comprehensive loss (30,615) (16,260)
Total stockholders' equity 3,634,636 477,511
Total liabilities and stockholders' equity $ 10,155,279 $ 7,566,852